论文部分内容阅读
奥扎格雷钠是一种高效强力的血栓素A2 (TXA2 )合成酶抑制剂,具有抗血小板聚集和扩血管作用,近年来用于急性缺血性脑梗死的治疗 [1]。2002年 10月至 2004年 1月,作者应用奥扎格雷钠治疗急性脑梗死 60例,现报道如下。1 临床资料1.1 一般资料 120例患者均证实为急性脑梗死,
Ozagrel sodium is a highly potent thromboxane A2 (TXA2) synthetase inhibitor with anti-platelet aggregation and vasodilator effects and has been used in the treatment of acute ischemic stroke in recent years [1]. October 2002 to January 2004, the authors apply sodium ozagrel acute cerebral infarction in 60 cases, are reported below. 1 Clinical data 1.1 General Information 120 patients were confirmed as acute cerebral infarction,